Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Omicron estimated to be 95.4% of coronavirus variants in U.S., CDC says

Published 01/04/2022, 11:29 AM
Updated 01/04/2022, 11:31 AM

(Reuters) - The Omicron variant was estimated to be 95.4% of the coronavirus strains circulating in the United States as of Jan. 1, the U.S. Centers for Disease Control and Prevention (CDC) said on Tuesday.

The variant has swiftly spread across the country since its detection on Dec. 1, replacing Delta as the dominant strain and sparking a new wave of infections that pushed daily cases near the 1 million mark on Monday.

The CDC said the variant accounted for an estimated 77% of cases in the week ended Dec. 25, up from the 58.6% projection it had disclosed last week.

The fast-spreading variant was first detected in southern Africa and Hong Kong in November and has since swept through the globe at lightning speed, although signs that it may cause milder symptoms than previous strains have offered some relief.

© Reuters. FILE PHOTO: A patient receives a coronavirus disease (COVID-19) test at Sparrow Laboratories Drive-Thru Services in Lansing, Michigan, U.S., December 27, 2021. REUTERS/Emily Elconin

The CDC had last week lowered its estimate for cases Omicron accounted for in the week ended Dec. 18 to 22% from 73%, citing additional data and discrepancies caused by the variant's rapid spread.

The Delta variant accounts for 4.6% of all U.S. COVID-19 cases as of Jan. 1, the CDC data showed.

Latest comments

Mild cold
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.